• Blog Post

Medication-assisted treatment and open communication achieve long-term results in treating PTSD

Jun 9th, 2020

Medication-Assisted Treatment for PTSD

Pharmacist Terri Taylor has worked behind the pharmacy counter for 32 years and has research experience at The University of Kansas School of Pharmacy. Over her health care career, Taylor has learned the key to treating disorders like post-traumatic stress disorder, or PTSD: medication-assisted treatment (MAT) and a strong relationship between the consumer and their care team.

Taylor serves many people living with PTSD at Genoa Healthcare’s Leavenworth, Kansas pharmacy, located within The Guidance Center.

“Leavenworth is a military town,” said Taylor, explaining why she sees higher rates of PTSD at her pharmacy. “We’re close to a military base, Fort Leavenworth, a federal prison and a Veteran’s Administration hospital.”

Almost eight percent of Americans will experience PTSD at some point during their lives,1 with even higher rates among people in the military and veterans.2 PTSD develops in some people who have experienced—or have seen others experience—a shocking or scary event. Symptoms typically include the following:

  • Re-experience: flashbacks, scary thoughts or bad dreams
  • Avoidance: staying away from places, objects, thoughts or feelings that remind them of the traumatic event
  • Anxiety: feeling tense, having trouble sleeping, having angry outbursts or being easily startled
  • Negative thoughts: having a hard time remembering important parts of the traumatic event, thinking negatively, feeling guilty or losing interest in activities that were once enjoyable

There is no medication that treats every symptom of PTSD. Some medications, however, can help ease symptoms, especially when taken along with therapy. MAT involves pairing these treatments together to reduce symptoms.3

“Although therapy is the standard for PTSD treatment, MAT is an important support tool,” explains Taylor. “This disorder can’t be cured, but it can be managed. The pharmacist, consumer and therapist have to work together to achieve long-term results.”

While symptoms of PTSD may wax and wane over time, there is always hope that they can still improve.

“It’s important to keep communication open with therapists and consumers as therapy progresses,” said Taylor. “That way, we can make changes to their medications so they are able to handle every changing symptom of PTSD.”

Sources

  1. Post-Traumatic Stress Disorder
  2. A Meta-Analysis of Risk Factors for Combat-Related PTSD among Military Personnel and Veterans
  3. Medication-Assisted Psychotherapy for PTSD

Recent Posts


  • Blog Post
Partnering with ACT teams to make an even bigger impact

Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...

  • Blog Post
  • Webinar
For consumers living with Tardive Dyskinesia, Genoa Healthcare’s Clinical Assistance Program offers personalized support

Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Clinical Insights
  • Webinar
Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...